Eculizumab in Severe Shiga-Toxin–Associated HUS
2011
This letter reports treatment of three children with severe, dialysis-requiring Shiga-toxin–induced hemolytic–uremic syndrome (HUS) with eculizumab, a monoclonal anti-C5 antibody. The condition of all three children improved rapidly.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
5
References
355
Citations
NaN
KQI